Shortages of essential drugs can have a significant impact on the health of children worldwide. In pediatric oncology, drug shortages are particularly impactful. Childhood cancer treatment relies heavily on the use of sterile injectable generic agents, which make up the majority of scarce medications.
Furthermore, there are no adequate substitutes or alternative drugs that can be used to treat these pediatric patients during a shortage. Beyond the immediate effect on clinical care, drug shortages may negatively impact enrollment in and the results of clinical trials, which account for the outstanding successes achieved in curing childhood cancer. Pediatric hematology-oncology nurses will benefit from an overview of the causes and significance of drug shortages, as well as strategies to manage their impact on patients and families.
- Career Development Event: Career Development Event: Your CV, Your Key to Professional Development (CDE)
- General Session: Gene Therapy and Gene Editing as a Treatment Option for Patients with Hemoglobinopathies (103)
- Clinical Pearls of Pediatric Brain Tumors for the Advanced Practice Nurse (222)
- Protect Your Professional Life: Beware of Predatory Publishers and Conferences (223)
- Adopt, Adapt, Advance: Utilizing Evidence Based Practice, Quality Improvement and Nursing Research to Transform Pediatric Hematology/Oncology Nursing Practice (224)
- Dyane Bunnell, MSN APRN AOCNS CPON®
Susie Burke, MA BSN CPNP CPHON®
Michele Casey, MN NP RN
Caity Hubrig, BSN RN CPN CPHON®
- CNE Hours: